Chemoinformaics analysis of octadec-9-en-18-olide
| Molecular Weight | 280.452 | nRot | 0 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 20 |
| Exact Molecular Weight | 280.24 | nRing | 1 |
| Solubility: LogS | -6.508 | nHRing | 1 |
| Solubility: LogP | 6.946 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 53.0014 |
| nHD | 0 | BPOL | 34.7066 |
| QED | 0.429 |
| Synth | 2.721 |
| Natural Product Likeliness | 0.605 |
| NR-PPAR-gamma | 0.246 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.016 |
| HIA | 0.004 |
| CACO-2 | -4.814 |
| MDCK | 0.0000243 |
| BBB | 0.133 |
| PPB | 0.969643 |
| VDSS | 2.353 |
| FU | 0.0193508 |
| CYP1A2-inh | 0.861 |
| CYP1A2-sub | 0.17 |
| CYP2c19-inh | 0.537 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.347 |
| CYP2c9-sub | 0.93 |
| CYP2d6-inh | 0.137 |
| CYP2d6-sub | 0.111 |
| CYP3a4-inh | 0.461 |
| CYP3a4-sub | 0.056 |
| CL | 6.89 |
| T12 | 0.271 |
| hERG | 0.268 |
| Ames | 0.008 |
| ROA | 0.022 |
| SkinSen | 0.973 |
| Carcinogencity | 0.256 |
| EI | 0.974 |
| Respiratory | 0.755 |
| NR-Aromatase | 0.238 |
| Antiviral | Yes |
| Prediction | 0.517188 |